-
Mashup Score: 4Generic but Expensive: Why Prices Can Remain High for Off-Patent Drugs | Hastings Law Journal - 3 year(s) ago
Frazer A. Tessema, Aaron S. Kesselheim, Michael S. Sinha Volume 71, Issue 4, 1019-1052 Brand-name prescription drugs are sold at extremely high prices in the US because patents and other market exclusivities provided by the government allow manufacturers to exclude direct competition. This period of market […]
Categories: Cardiologists, Latest HeadlinesTweet
Looking forward to joining @SetonHallLaw @SHUHealthLaw tonight at 7pm for its Distinguished Health Law Guest Scholars series! I'll be discussing #GenericButExpensive (published in @HastingsLJ: https://t.co/P6yiKt7mz2) https://t.co/LJ1Lt1RvUZ